Fierce Pharma

Changes to a public health webpage undercut the medical community’s [...]

In an effort to break even by 2028, mRNA specialist [...]

Sun Pharma has launched an eye-opening awareness push about a [...]

Bayer’s Hyrnuo is catching up to Boehringer Ingelheim’s rival Hernexeos [...]

With a $140 million investment, Moderna will build a new [...]

With a fresh FDA endorsement for its drug plozasiran, Pasadena-based [...]

The bankruptcy reorganization plan will deliver $7.4 billion to creditors, [...]

Cytokinetics is following in the footsteps of Bristol Myers Squibb [...]

Biogen has had two years to gear up for the [...]

Days after joining its fellow GLP-1 giant, Eli Lilly, in [...]